AstraZeneca's COVID-19 vaccine trial in the United States is expected to resume as early as this week after the US Food and Drug Administration completed its review of a serious illness, four sources told Reuters. AstraZeneca's large, late-stage US trial…
Read MoreGilead In Deal With 5 Cos. To Make And Sell Remdesivir In 127 Countries
Gilead Sciences Inc. said it has signed non-exclusive voluntary licensing agreements with five generic drug makers to manufacture remdesivir, its experimental COVID-19 drug, for distribution in 127 countries. Foster City, California-based Gilead signed the licensing deals with five generic drug…
Read More